Pathogen Detection and Community Acquired Pneumonia
Status: | Active, not recruiting |
---|---|
Conditions: | Pneumonia |
Therapuetic Areas: | Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | Any |
Updated: | 6/9/2018 |
Start Date: | January 2017 |
End Date: | December 2018 |
Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-Acquired Pneumonia
Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using
current diagnostic tests to the number detected using the BioFire Diagnostics investigational
polymerase chain reaction (PCR) platform.
current diagnostic tests to the number detected using the BioFire Diagnostics investigational
polymerase chain reaction (PCR) platform.
Patients diagnosed in the emergency department with CAP that requires hospitalization provide
a sputum sample for culture and sensitivity testing, urine for detection of S. pneumonia and
L. pneumophila, an anterior nasal swab for S. aureus PCR, a nasopharyngeal swab for S.
pneumonia PCR and the FilmArray LRTI v.2.0 IUO Panel, and blood for procalcitonin testing
and, in cases in which the patient is suffering rigors and hypotension, cultures. As part of
this study, sputum or sputum equivalent will be acquired for testing using the FilmArray LRTI
v.2.0 IUO Panel.
a sputum sample for culture and sensitivity testing, urine for detection of S. pneumonia and
L. pneumophila, an anterior nasal swab for S. aureus PCR, a nasopharyngeal swab for S.
pneumonia PCR and the FilmArray LRTI v.2.0 IUO Panel, and blood for procalcitonin testing
and, in cases in which the patient is suffering rigors and hypotension, cultures. As part of
this study, sputum or sputum equivalent will be acquired for testing using the FilmArray LRTI
v.2.0 IUO Panel.
Inclusion Criteria:
- Emergency Department physician diagnosis of CAP requiring hospitalization
Exclusion Criteria:
- Inability to obtain sputum or sputum equivalent
We found this trial at
1
site
Click here to add this to my saved trials
